Research Article

Novel Predictive Scoring System for Intravenous Immunoglobulin Resistance Helps Timely Intervention in Kawasaki Disease: The Chinese Experience

Table 1

Comparison of clinical and laboratory variables between IVIG responders and IVIG nonresponders.

VariablesIVIG responders n = 665IVIG nonresponders n = 38P values

Male403 (60.60%)26 (68.42%)0.336
Age (month)26.54 ± 21.3932.24 ± 31.470.278
ESR (mm/hr)63.63 ± 26.3072.26 ± 37.150.166
BNP (pg/mL)159.72 ± 199.13403.72 ± 840.810.091
PCT (ng/mL)1.13 ± 1.812.70 ± 4.440.036
SF (ng/mL)169.84 ± 141.99294.01 ± 238.230.003
T lymphocyte (/μL)2,147.40 ± 1,153.441,446.33 ± 1,064.170.001
CD4+ T lymphocyte (/μL)1,368.83 ± 830.40912.50 ± 745.040.002
SIL-2R (U/mL)2,187.97 ± 1,435.443,293.73 ± 2,469.470.021
IL-6 (pg/mL)39.24 ± 76.4898.13 ± 162.750.058
ALT (U/L)35.51 ± 49.8069.63 ± 92.540.030
AST (U/L)38.66 ± 42.5754.89 ± 67.680.152
Albumin (g/L)37.09 ± 4.4032.31 ± 5.18
Total bilirubin (μmol/L)6.39 ± 5.8913.39 ± 14.160.004
Direct bilirubin (μmol/L)2.83 ± 4.008.76 ± 11.980.004
Sodium (mmol/L)135.95 ± 2.5134.21 ± 3.01
CRP (mg/L)51.17 ± 44.5086.37 ± 65.680.002
WBC (×109/L)11.84 ± 5.2119.89 ± 9.92
Percentage of neutrophils (%)51.28 ± 19.8272.96 ± 14.98
Hb (g/L)106.72 ± 10.81101.08 ± 10.570.002
Plt (×109/L)385.37 ± 127.59334.45 ± 164.300.019

Data is presented as number (%) or mean ± standard deviation.